2/27
02:57 pm
amph
Why Amphastar Pharmaceuticals (AMPH) Shares Are Plunging Today [Yahoo! Finance]
Low
Report
Why Amphastar Pharmaceuticals (AMPH) Shares Are Plunging Today [Yahoo! Finance]
2/27
11:41 am
amph
Amphastar Pharmaceuticals (AMPH) had its price target lowered by Wells Fargo & Company from $34.00 to $30.00. They now have an "overweight" rating on the stock.
High
Report
Amphastar Pharmaceuticals (AMPH) had its price target lowered by Wells Fargo & Company from $34.00 to $30.00. They now have an "overweight" rating on the stock.
2/27
08:02 am
amph
Amphastar Pharmaceuticals (AMPH) had its price target lowered by Needham & Company LLC from $34.00 to $30.00. They now have a "buy" rating on the stock.
Medium
Report
Amphastar Pharmaceuticals (AMPH) had its price target lowered by Needham & Company LLC from $34.00 to $30.00. They now have a "buy" rating on the stock.
2/26
10:12 pm
amph
Amphastar Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Amphastar Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
05:39 pm
amph
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7% [Yahoo! Finance]
High
Report
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7% [Yahoo! Finance]
2/25
12:46 pm
amph
Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
Low
Report
Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
2/20
06:04 am
amph
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026 [Yahoo! Finance]
Low
Report
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026 [Yahoo! Finance]
2/14
01:53 am
amph
Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Mixed Recent Share Performance [Yahoo! Finance]
Low
Report
Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Mixed Recent Share Performance [Yahoo! Finance]
2/13
04:03 pm
amph
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know [Yahoo! Finance]
Low
Report
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know [Yahoo! Finance]
1/16
05:41 am
amph
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead [Yahoo! Finance]
1/15
04:03 pm
amph
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving [Yahoo! Finance]
Low
Report
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving [Yahoo! Finance]
1/12
05:53 pm
amph
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today [Yahoo! Finance]
Low
Report
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today [Yahoo! Finance]
1/12
06:17 am
amph
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound [Yahoo! Finance]
Medium
Report
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound [Yahoo! Finance]
12/23
10:32 am
amph
Amphastar Director Sells 16,679 Shares for $441,800 [Yahoo! Finance]
Low
Report
Amphastar Director Sells 16,679 Shares for $441,800 [Yahoo! Finance]
12/16
11:30 am
amph
Will FDA Approval of an In-House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? [Yahoo! Finance]
Low
Report
Will FDA Approval of an In-House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? [Yahoo! Finance]
12/16
07:37 am
amph
Amphastar: Baqsimi Props Up Flat Growth, But 2026 Guidance Looks Fragile [Seeking Alpha]
Low
Report
Amphastar: Baqsimi Props Up Flat Growth, But 2026 Guidance Looks Fragile [Seeking Alpha]
12/12
07:05 pm
amph
2 Russell 2000 Stocks for Long-Term Investors and 1 Facing Challenges [Yahoo! Finance]
Medium
Report
2 Russell 2000 Stocks for Long-Term Investors and 1 Facing Challenges [Yahoo! Finance]
12/10
07:17 am
amph
Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by analysts at Barclays PLC to a "hold" rating.
Low
Report
Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by analysts at Barclays PLC to a "hold" rating.
12/9
09:06 am
amph
Amphastar Pharmaceuticals (NASDAQ:AMPH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $30.00 price target on the stock.
Low
Report
Amphastar Pharmaceuticals (NASDAQ:AMPH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $30.00 price target on the stock.
12/3
03:43 pm
amph
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why [Yahoo! Finance]
Neutral
Report
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why [Yahoo! Finance]
11/29
10:57 am
amph
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? [Yahoo! Finance]
Low
Report
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? [Yahoo! Finance]
11/28
09:35 pm
amph
A Look at Amphastar Pharmaceuticals (AMPH) Valuation Following Strong Quarterly Results and Pipeline Progress [Yahoo! Finance]
Low
Report
A Look at Amphastar Pharmaceuticals (AMPH) Valuation Following Strong Quarterly Results and Pipeline Progress [Yahoo! Finance]